1. Home
  2. EVC vs CMPX Comparison

EVC vs CMPX Comparison

Compare EVC & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVC
  • CMPX
  • Stock Information
  • Founded
  • EVC 1996
  • CMPX 2014
  • Country
  • EVC United States
  • CMPX United States
  • Employees
  • EVC N/A
  • CMPX N/A
  • Industry
  • EVC Broadcasting
  • CMPX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVC Industrials
  • CMPX Health Care
  • Exchange
  • EVC Nasdaq
  • CMPX Nasdaq
  • Market Cap
  • EVC 188.3M
  • CMPX 291.8M
  • IPO Year
  • EVC 2000
  • CMPX N/A
  • Fundamental
  • Price
  • EVC $2.45
  • CMPX $2.78
  • Analyst Decision
  • EVC
  • CMPX Strong Buy
  • Analyst Count
  • EVC 0
  • CMPX 9
  • Target Price
  • EVC N/A
  • CMPX $12.67
  • AVG Volume (30 Days)
  • EVC 352.0K
  • CMPX 929.9K
  • Earning Date
  • EVC 08-07-2025
  • CMPX 08-11-2025
  • Dividend Yield
  • EVC 8.16%
  • CMPX N/A
  • EPS Growth
  • EVC N/A
  • CMPX N/A
  • EPS
  • EVC N/A
  • CMPX N/A
  • Revenue
  • EVC $378,623,000.00
  • CMPX $850,000.00
  • Revenue This Year
  • EVC $64.06
  • CMPX N/A
  • Revenue Next Year
  • EVC N/A
  • CMPX N/A
  • P/E Ratio
  • EVC N/A
  • CMPX N/A
  • Revenue Growth
  • EVC 23.10
  • CMPX N/A
  • 52 Week Low
  • EVC $1.58
  • CMPX $0.77
  • 52 Week High
  • EVC $2.73
  • CMPX $4.08
  • Technical
  • Relative Strength Index (RSI)
  • EVC 63.90
  • CMPX 68.90
  • Support Level
  • EVC $2.19
  • CMPX $2.50
  • Resistance Level
  • EVC $2.46
  • CMPX $2.71
  • Average True Range (ATR)
  • EVC 0.12
  • CMPX 0.19
  • MACD
  • EVC 0.01
  • CMPX 0.01
  • Stochastic Oscillator
  • EVC 97.67
  • CMPX 87.14

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: